MedPath

Clinical Study and Mechanism of Jiakangtongzhi Formulation in the Treatment of Graves Disease(Yin Deficiency and Yang Excess, Liver Depression and Phlegm Obstruction)

Phase 1
Conditions
Graves Disease
Registration Number
ITMCTR2022000051
Lead Sponsor
Guang 'anmen Hospital, Chinese Academy of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

? Meet the diagnostic criteria of graves disease in western medicine ; ? Meet the diagnostic criteria of TCM syndrome; ? Aged between 18 and 65 years, and gender is not limited; ? Informed consent has been signed.

Exclusion Criteria

?Pregnant and lactating women and those are planing for pregnancy in the near future; ? Patients with severe primary diseases such as cardiovascular and cerebrovascular vessels, liver, kidney, and hematopoietic system, or cancer and mental illness; ?Patients with hyperthyroidism crisis; ?Patients with exophthalmus infiltrative; ?Allergic constitution or allergic history to multiple drugs; l? Patients treated with either isotope or surgery; ? Patients who have participated in the clinical studies of other drugs in the past one month; ? Those who are not fully understood and unwilling to participate in this study, or who reduce the possibility of enrollment or poor compliance, such as unstable work and living place, according to the judgment of the researcher.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath